Publications

Found 1 results
Filters: Author is U. Chuensumran  [Clear All Filters]
2012
K. Suriyaprom, Phonrat, B., Chuensumran, U., Tungtrongchitr, A., and Tungtrongchitr, R., Association of HTTLPR and 5-HT2A T102C polymorphisms with smoking characteristics and anthropometric profiles of Thai males, vol. 11, pp. 4360-4369, 2012.
Abdolmaleky HM, Faraone SV, Glatt SJ and Tsuang MT (2004). Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 67: 53-62. http://dx.doi.org/10.1016/S0920-9964(03)00183-X   Barnes NM and Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083- 1152. http://dx.doi.org/10.1016/S0028-3908(99)00010-6   Batra V, Patkar AA, Berrettini WH, Weinstein SP, et al. (2003). The genetic determinants of smoking. Chest 123: 1730- 1739. http://dx.doi.org/10.1378/chest.123.5.1730 PMid:12740294   Chen K, Yang W, Grimsby J and Shih JC (1992). The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Mol. Brain Res. 14: 20-26. http://dx.doi.org/10.1016/0169-328X(92)90005-V   Chu SL, Xiao D, Wang C and Jing H (2009). Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males. Chin. Med. J. 122: 1365-1368.   Coto E, Reguero JR, Alvarez V, Morales B, et al. (2003). 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin. Sci. 104: 241-245. http://dx.doi.org/10.1042/CS20020246 PMid:12605580   Currie PJ and Coscina DV (1998). 5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient. Brain Res. 803: 212-217. http://dx.doi.org/10.1016/S0006-8993(98)00643-X   Degiampietro P, Peheim E, Drew D, Graf H, et al. (1987). Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J. Clin. Chem. Clin. Biochem. 25: 711-717. PMid:3694128   do Prado-Lima PA, Chatkin JM, Taufer M, Oliveira G, et al. (2004). Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128B: 90-93. http://dx.doi.org/10.1002/ajmg.b.30004 PMid:15211639   Ebdrup BH, Rasmussen H, Arnt J and Glenthoj B (2011). Serotonin 2A receptor antagonists for treatment of schizophrenia. Expert. Opin. Investig. Drugs 20: 1211-1223. http://dx.doi.org/10.1517/13543784.2011.601738 PMid:21740279   Erritzoe D, Frokjaer VG, Haugbol S, Marner L, et al. (2009). Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 46: 23-30. http://dx.doi.org/10.1016/j.neuroimage.2009.01.050 PMid:19457377   Gerra G, Garofano L, Zaimovic A, Moi G, et al. (2005). Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B: 73-78. http://dx.doi.org/10.1002/ajmg.b.30173 PMid:15806583   Greenberg BD, Tolliver TJ, Huang SJ, Li Q, et al. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88: 83-87. http://dx.doi.org/10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0   Heils A, Teufel A, Petri S, Stober G, et al. (1996). Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66: 2621-2624. http://dx.doi.org/10.1046/j.1471-4159.1996.66062621.x PMid:8632190   Heils A, Mossner R and Lesch KP (1997). The human serotonin transporter gene polymorphism--basic research and clinical implications. J. Neural Transm. 104: 1005-1014. http://dx.doi.org/10.1007/BF01273314 PMid:9503253   Huang S, Cook DG, Hinks LJ, Chen XH, et al. (2005). CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet. Genomics 15: 839-850. http://dx.doi.org/10.1097/01213011-200512000-00002 PMid:16272956   Hwu HG and Chen CH (2000). Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am. J. Med. Genet. 96: 797-800. http://dx.doi.org/10.1002/1096-8628(20001204)96:6<797::AID-AJMG20>3.0.CO;2-K   Iordanidou M, Tavridou A, Petridis I, Kyroglou S, et al. (2010). Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Drug Alcohol Depend. 108: 70-76. http://dx.doi.org/10.1016/j.drugalcdep.2009.11.015 PMid:20060656   Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, et al. (1999). Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomarkers Prev. 8: 831-833. PMid:10498403   Kato M, Zanardi R, Rossini D, De Ronchi D, et al. (2009). 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry Res. 167: 97-105. http://dx.doi.org/10.1016/j.psychres.2007.12.012 PMid:19361869   Keltikangas-Jarvinen L and Salo J (2009). Dopamine and serotonin systems modify environmental effects on human behavior: a review. Scand. J. Psychol. 50: 574-582. http://dx.doi.org/10.1111/j.1467-9450.2009.00785.x PMid:19930256   Lane HY, Liu YC, Huang CL, Chang YC, et al. (2006). Risperidone-related weight gain: genetic and nongenetic predictors. J. Clin. Psychopharmacol. 26: 128-134. http://dx.doi.org/10.1097/01.jcp.0000203196.65710.2b PMid:16633140   Lerman C, Shields PG, Audrain J, Main D, et al. (1998). The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomarkers Prev. 7: 253-255. PMid:9521442   Lerman C, Caporaso NE, Audrain J, Main D, et al. (2000). Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry 5: 189-192. http://dx.doi.org/10.1038/sj.mp.4000672 PMid:10822347   Lesch KP, Bengel D, Heils A, Sabol SZ, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531. http://dx.doi.org/10.1126/science.274.5292.1527 PMid:8929413   Li MD, Cheng R, Ma JZ and Swan GE (2003). A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98: 23-31. http://dx.doi.org/10.1046/j.1360-0443.2003.00295.x PMid:12492752   Mihailescu S, Palomero-Rivero M, Meade-Huerta P, Maza-Flores A, et al. (1998). Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360: 31-36. http://dx.doi.org/10.1016/S0014-2999(98)00658-X   Munafo MR, Johnstone EC, Wileyto EP, Shields PG, et al. (2006). Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev. 15: 398-400. http://dx.doi.org/10.1158/1055-9965.EPI-05-0648 PMid:16492936   Murphy DL, Lerner A, Rudnick G and Lesch KP (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4: 109-123. http://dx.doi.org/10.1124/mi.4.2.8 PMid:15087484   Polesskaya OO and Sokolov BP (2002). Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67: 812-822. http://dx.doi.org/10.1002/jnr.10173 PMid:11891796   Polina ER, Contini V, Hutz MH and Bau CH (2009). The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug Alcohol Depend. 101: 128-131. http://dx.doi.org/10.1016/j.drugalcdep.2008.11.001 PMid:19111403   Rosmond R, Bouchard C and Björntorp P (2002). 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes. Res. 10: 585-589. http://dx.doi.org/10.1038/oby.2002.79 PMid:12105278   Terayama H, Itoh M, Fukunishi I and Iwahashi K (2004). The serotonin-2A receptor polymorphism and smoking behavior in Japan. Psychiatr. Genet. 14: 195-197. http://dx.doi.org/10.1097/00041444-200412000-00005 PMid:15564892   Turecki G, Briere R, Dewar K, Antonetti T, et al. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry 156: 1456-1458. PMid:10484964   Tyndale RF (2003). Genetics of alcohol and tobacco use in humans. Ann. Med. 35: 94-121. http://dx.doi.org/10.1080/07853890310010014 PMid:12795339   Vink JM, Smit AB, de Geus EJ, Sullivan P, et al. (2009). Genome-wide association study of smoking initiation and current smoking. Am. J. Hum. Genet. 84: 367-379. http://dx.doi.org/10.1016/j.ajhg.2009.02.001 PMid:19268276 PMCid:2667987   White MJ, Young RM, Morris CP and Lawford BR (2011). Cigarette smoking in young adults: the influence of the HTR2A T102C polymorphism and punishment sensitivity. Drug Alcohol Depend. 114: 140-146. PMid:21035274   Yonan AL, Palmer AA and Gilliam TC (2006). Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr. Genet. 16: 31-34. http://dx.doi.org/10.1097/01.ypg.0000174393.79883.05 PMid:16395127   Zaniewska M, McCreary AC, Wydra K and Filip M (2010). Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. Neuropharmacology 58: 1140-1146. http://dx.doi.org/10.1016/j.neuropharm.2010.02.006 PMid:20153341   Zeidler R, Albermann K and Lang S (2007). Nicotine and apoptosis. Apoptosis 12: 1927-1943. http://dx.doi.org/10.1007/s10495-007-0102-8 PMid:17846896